Advarra

JUNE 27, 2023

Clinical trials are studies involving human volunteers to research ways to prevent, detect, and treat various medical conditions. The goal is to identify safer, more effective methods of treating illnesses using new drugs or new combinations of existing drugs.

Clinical Research 52

Clinical Research Research Clinical Trials Trials 52

Drug Discovery World

JUNE 9, 2023

Phase III pulmonary fibrosis drug trial fails Bellerophon Therapeutics has announced it will close its Phase III study of INOpulse, its treatment for fibrotic Interstitial Lung Disease (fILD), after the trail failed to meet its primary endpoint.

Clinical Trials 130

Clinical Trials FDA Trials Drugs 130

Drug Discovery World

FEBRUARY 10, 2023

Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.

Clinical Trials 130

Clinical Trials Trials Drugs Vaccine 130

Drug Discovery World

FEBRUARY 20, 2023

While changes to how clinical trials are conducted and trial data is managed are likely in 2023 and going forward, and we can expect less attention on Covid-19, it is a safe bet that oncology will remain an area of focus for many companies. The post What are the top disease areas for clinical drug trials?

Trials 130

Trials Drug Trials Disease Clinical Trials 130

PPD

MARCH 28, 2024

According to Jeffries Equity Research, funding totals exceeded $15 billion in January and February, marking the best monthly tallies in over a year. Strategic partnerships with trusted contract research organizations (CROs) can significantly enhance the appeal of biotech companies to investors.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Conversations in Drug Development Trends

NOVEMBER 3, 2022

BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. Looking to diversify the reach of your orphan drug trial?

Disease 52

Disease Clinical Trials Trials International 52

The Pharma Data

NOVEMBER 10, 2020

Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the Clinical Trials on Alzheimer’s Disease (CTAD) virtual conference in early November. Jeff Dage, Ph.D., But, as Iwatsubo cautioned, “We are at the early stages.

Disease 52

Disease Clinical Trials Trials Research 52